Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Nitroglycerin to Ameliorate Coronary Artery Spasm During Focal Pulsed-Field Ablation for Atrial Fibrillation

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F24%3A00009904" target="_blank" >RIV/00023884:_____/24:00009904 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://www-sciencedirect-com.ezproxy.lib.cas.cz/science/article/abs/pii/S2405500X24000112?via%3Dihub" target="_blank" >https://www-sciencedirect-com.ezproxy.lib.cas.cz/science/article/abs/pii/S2405500X24000112?via%3Dihub</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.jacep.2023.12.015" target="_blank" >10.1016/j.jacep.2023.12.015</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Nitroglycerin to Ameliorate Coronary Artery Spasm During Focal Pulsed-Field Ablation for Atrial Fibrillation

  • Popis výsledku v původním jazyce

    BACKGROUND In treating atrial fibrillation, pulsed - field ablation (PFA) has comparable ef ficacy to conventional thermal ablation, but with important safety advantages: no esophageal injury or pulmonary vein stenosis, and rare phrenic nerve injury. However, when PFA is delivered in proximity to coronary arteries using a pentaspline catheter, which generates a broad electrical field, severe vasospasm can be provoked. OBJECTIVES The authors sought to study the vasospastic potential of a focal PFA catheter with a narrower electrical field and develop a preventive strategy with nitroglycerin. METHODS During atrial fibrillation ablation, a focal PFA catheter was used for cavotricuspid isthmus ablation. Angiography of the right coronary artery (some with fractional flow reserve measurement) was performed before, during, and after PFA. Beyond no nitroglycerin (n = 5), and a few testing strategies (n = 8), 2 primary nitroglycerin administration strategies were studied: 1) multiple boluses (3-2 mg every 2 min) into the right atrium (n =10), and 2) a bolus (3 mg) into the right atrium with continuous peripheral intravenous infusion (1 mg/min; n = 10). RESULTS Without nitroglycerin, cavotricuspid isthmus ablation provoked moderate -severe vasospasm in 4 of 5 (80%) patients (fractional flow reserve 0.71 +/- 0.08). With repetitive nitroglycerin boluses, severe spasm did not occur, and mild -moderate vasospasm occurred in only 2 of 10 (20%). Using the bolus + infusion strategy, severe and mild -moderate spasm occurred in 1 and 3 of 10 patients (aggregate 40%). No patient had ST -segment changes. CONCLUSIONS Ablation of the cavotricuspid isthmus using a focal PFA catheter routinely provokes right coronary vasospasm. Pretreatment with high doses of parenteral nitroglycerin prevents severe spasm. (J Am Coll Cardiol EP 2024;10:885 -896) (c) 2024 by the American College of Cardiology Foundation.

  • Název v anglickém jazyce

    Nitroglycerin to Ameliorate Coronary Artery Spasm During Focal Pulsed-Field Ablation for Atrial Fibrillation

  • Popis výsledku anglicky

    BACKGROUND In treating atrial fibrillation, pulsed - field ablation (PFA) has comparable ef ficacy to conventional thermal ablation, but with important safety advantages: no esophageal injury or pulmonary vein stenosis, and rare phrenic nerve injury. However, when PFA is delivered in proximity to coronary arteries using a pentaspline catheter, which generates a broad electrical field, severe vasospasm can be provoked. OBJECTIVES The authors sought to study the vasospastic potential of a focal PFA catheter with a narrower electrical field and develop a preventive strategy with nitroglycerin. METHODS During atrial fibrillation ablation, a focal PFA catheter was used for cavotricuspid isthmus ablation. Angiography of the right coronary artery (some with fractional flow reserve measurement) was performed before, during, and after PFA. Beyond no nitroglycerin (n = 5), and a few testing strategies (n = 8), 2 primary nitroglycerin administration strategies were studied: 1) multiple boluses (3-2 mg every 2 min) into the right atrium (n =10), and 2) a bolus (3 mg) into the right atrium with continuous peripheral intravenous infusion (1 mg/min; n = 10). RESULTS Without nitroglycerin, cavotricuspid isthmus ablation provoked moderate -severe vasospasm in 4 of 5 (80%) patients (fractional flow reserve 0.71 +/- 0.08). With repetitive nitroglycerin boluses, severe spasm did not occur, and mild -moderate vasospasm occurred in only 2 of 10 (20%). Using the bolus + infusion strategy, severe and mild -moderate spasm occurred in 1 and 3 of 10 patients (aggregate 40%). No patient had ST -segment changes. CONCLUSIONS Ablation of the cavotricuspid isthmus using a focal PFA catheter routinely provokes right coronary vasospasm. Pretreatment with high doses of parenteral nitroglycerin prevents severe spasm. (J Am Coll Cardiol EP 2024;10:885 -896) (c) 2024 by the American College of Cardiology Foundation.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30201 - Cardiac and Cardiovascular systems

Návaznosti výsledku

  • Projekt

  • Návaznosti

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Ostatní

  • Rok uplatnění

    2024

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    JACC: Clinical Electrophysiology

  • ISSN

    2405-500X

  • e-ISSN

  • Svazek periodika

    10

  • Číslo periodika v rámci svazku

    5

  • Stát vydavatele periodika

    US - Spojené státy americké

  • Počet stran výsledku

    12

  • Strana od-do

    885-896

  • Kód UT WoS článku

    001246649500001

  • EID výsledku v databázi Scopus

    2-s2.0-85187574086